- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01211015
Endoplasmic Reticulum Stress in Chronic Respiratory Diseases
September 28, 2010 updated by: Chonbuk National University
Endoplasmic Reticulum (ER) Stress in Patients With Various Chronic Pulmonary Diseases
Aim: To investigate whether ER stress is implicated in the pathogenesis of various pulmonary disorders
Measurement:
Unfolded protein responses (UPRs) in blood (PBMCs)of patients
- CHOP
- GRP 78 and so on
Unfolded protein responses (UPRs) in blood (PBMCs)of healthy controls
- CHOP
- GRP 78 and so on
Study Overview
Status
Unknown
Study Type
Observational
Enrollment (Anticipated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Jeonbuk
-
Jeonju, Jeonbuk, Korea, Republic of, 561-180
- Recruiting
- Chonbuk National University Hospital
-
Contact:
- Yong Chul Lee, MD, PhD
- Phone Number: 1664 82-63-250-1664
- Email: leeyc@chonbuk.ac.kr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Control group
- healthy control (volunteer)
Disease group
- chronic pulmonary lung diseases including asthma, COPD, ILD, and lung cancer
Description
Inclusion Criteria:
- > 18 yrs
- Definitive diagnosis as chronic pulmonary diseases by physician
Exclusion Criteria:
- Any other chronic medical illness such as DM, HTN, and other malignancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Control group
healthy control group
|
|
Disease group
asthma, COPD, ILD, lung malignancy
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2010
Study Registration Dates
First Submitted
September 28, 2010
First Submitted That Met QC Criteria
September 28, 2010
First Posted (Estimate)
September 29, 2010
Study Record Updates
Last Update Posted (Estimate)
September 29, 2010
Last Update Submitted That Met QC Criteria
September 28, 2010
Last Verified
September 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RCPD ER stress
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Interstitial Lung Diseases
-
Boehringer IngelheimRecruitingInterstitial Lung Diseases | Familial Pulmonary Fibrosis | Interstitial Lung AbnormalitiesUnited States, Belgium, Australia, Canada, Germany, United Kingdom, Italy, France, Japan, Netherlands, Spain, Argentina, South Korea
-
Fondazione IRCCS Policlinico San Matteo di PaviaRecruitingInterstitial Lung DiseaseItaly
-
Bastiaan DriehuysNational Heart, Lung, and Blood Institute (NHLBI); University of Iowa; Children... and other collaboratorsCompletedInterstitial Lung DiseasesUnited States
-
Shanghai East HospitalRegend TherapeuticsCompletedInterstitial Lung DiseasesChina
-
Matthias GrieseTerminatedInterstitial Lung Disease | Diffuse Parenchymal Lung Disease | Children´s Interstitial Lung DiseaseGermany
-
Boehringer IngelheimNo longer availableLung Diseases, Interstitial (in Pediatric Populations) | Childhood Interstitial Lung Disease (chILD)
-
Nuwacell Biotechnologies Co., Ltd.Not yet recruiting
-
Boehringer IngelheimNot yet recruitingInterstitial Lung DiseasesUnited States, Taiwan, China, Canada, Belgium, Spain, Germany, Italy, Japan, Mexico, Netherlands, Brazil, Argentina, Finland, South Korea
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
Istinye UniversityNot yet recruitingInterstitial Lung Disease